ALZN
Price:
$1.31
Market Cap:
$5.86M
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system ...[Read more]
Industry
Biotechnology
IPO Date
2021-06-15
Stock Exchange
NASDAQ
Ticker
ALZN
According to Alzamend Neuro, Inc.’s latest financial reports and current stock price. The company's current ROE is 276.87%. This represents a change of 288.57% compared to the average of 71.25% of the last 4 quarters.
The mean historical ROE of Alzamend Neuro, Inc. over the last ten years is 7.03%. The current 276.87% ROE has changed -96.06% with respect to the historical average. Over the past ten years (40 quarters), ALZN's ROE was at its highest in in the July 2023 quarter at 3.13%. The ROE was at its lowest in in the July 2016 quarter at -400.17%.
Average
7.03%
Median
-92.91%
Minimum
-1534.32%
Maximum
65.52%
Discovering the peaks and valleys of Alzamend Neuro, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.72%
Maximum Annual ROE = 65.52%
Minimum Annual Increase = -178.49%
Minimum Annual ROE = -1534.32%
Year | ROE | Change |
---|---|---|
2024 | 383.46% | -178.49% |
2023 | -488.53% | 425.82% |
2022 | -92.91% | -64.06% |
2021 | -258.51% | -51.68% |
2020 | -535.02% | -65.13% |
2019 | -1534.32% | 3.72% |
2018 | -40.17% | -114.97% |
2017 | 268.39% | -99.59% |
The current ROE of Alzamend Neuro, Inc. (ALZN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-65.99%
5-year avg
-198.30%
10-year avg
7.03%
Alzamend Neuro, Inc.’s ROE is greater than TRACON Pharmaceuticals, Inc. (-237.65%), greater than Solid Biosciences Inc. (-58.75%), greater than Kezar Life Sciences, Inc. (-59.73%), greater than Senti Biosciences, Inc. (-154.84%), less than X4 Pharmaceuticals, Inc. (0%), greater than Inozyme Pharma, Inc. (-32.51%), greater than Terns Pharmaceuticals, Inc. (-88.42%), greater than Day One Biopharmaceuticals, Inc. (-32.76%), greater than HOOKIPA Pharma Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-49.25%), greater than VectivBio Holding AG (-32.99%), greater than Molecular Partners AG (-56.92%), greater than Adverum Biotechnologies, Inc. (-39.16%), greater than Alector, Inc. (-65.14%), greater than Adagene Inc. (-108.77%), greater than null (-50.10%),
Company | ROE | Market cap |
---|---|---|
-237.65% | $107.51K | |
-58.75% | $216.15M | |
-59.73% | $54.72M | |
-154.84% | $9.96M | |
0% | $57.64M | |
-32.51% | $180.51M | |
-88.42% | $491.80M | |
-32.76% | $1.38B | |
-22.40% | $20.76M | |
-49.25% | $142.39M | |
-32.99% | $1.06B | |
-56.92% | $216.81M | |
-39.16% | $125.65M | |
-65.14% | $385.85M | |
-108.77% | $97.11M | |
-50.10% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alzamend Neuro, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alzamend Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alzamend Neuro, Inc.'s ROE?
How is the ROE calculated for Alzamend Neuro, Inc. (ALZN)?
What is the highest ROE for Alzamend Neuro, Inc. (ALZN)?
What is the 3-year average ROE for Alzamend Neuro, Inc. (ALZN)?
What is the 5-year average ROE for Alzamend Neuro, Inc. (ALZN)?
How does the current ROE for Alzamend Neuro, Inc. (ALZN) compare to its historical average?